GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovita Biological Technology Co Ltd (SHSE:688253) » Definitions » Total Equity

Innovita Biological Technology Co (SHSE:688253) Total Equity : ¥2,043.7 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Innovita Biological Technology Co Total Equity?

Innovita Biological Technology Co's total equity for the quarter that ended in Sep. 2024 was ¥2,043.7 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Innovita Biological Technology Co Total Equity Historical Data

The historical data trend for Innovita Biological Technology Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovita Biological Technology Co Total Equity Chart

Innovita Biological Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 114.40 668.01 738.17 1,689.34 1,842.01

Innovita Biological Technology Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,754.87 1,842.01 1,989.56 1,993.67 2,043.71

Innovita Biological Technology Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Innovita Biological Technology Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=2065.655-223.647
=1,842.0

Innovita Biological Technology Co's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=2170.134-126.424
=2,043.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovita Biological Technology Co Total Equity Related Terms

Thank you for viewing the detailed overview of Innovita Biological Technology Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovita Biological Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Courtyard, Haiying Road, 1st Floor, 2nd Floor, Building 6, Fengtai District, Beijing, CHN, 100071
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
Executives
Chen Fu Kang senior management
Zhang Xiao Gang Directors, senior managers
Zhang Xiu Jie Directors, senior managers
Chen Ting You Director, core technical staff
Wang Heng Qiang Core technical personnel
Zhao Xiu Juan Directors, senior managers
Ding Zhi Core technical personnel

Innovita Biological Technology Co Headlines

No Headlines